Elsilimomab Antibody
Elsilimomab (B-E8) is an anti-interleukin-6 (IL-6) monoclonal antibody. It is utilized in research on multiple myeloma and renal cell carcinoma to study its role in blocking IL-6-mediated signaling, which can inhibit mutant clone-induced stromal senescence in hematopoietic models, as explored in vitro.
Product Specifications
Product Name Alternative
Anti-Human IL6 Recombinant Antibody, Anti-IL-6 MAB B-E8, BE8, B-E8
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
7.54 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.96 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881775-100 1x 100 µL
CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) (CFTR/1775R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-E945815-50MG 50 mg
(5b,6a)-6-Ethyl-3,7-dioxo-cholan-24-oic Acid
Sign In for Pricing
View Details 
E-BC-K611-M-01 48 T (48 samples)
Pyruvate Kinase (PK) Activity Assay Kit
Sign In for Pricing
View Details